• Sanctions withdrawn against California COVID-19 test lab

    The California Department of Public Health's Valencia Branch Laboratory won't be issued sanctions after the department investigated the COVID-19 testing lab for much of the year, according to a Nov. 22 The Press Democrat report.
  • Cardinal Health eases lab understaffing with supply automation

    Dublin, Ohio-based lab product manufacturer Cardinal Health is opening its automated supply management business to clinical labs, the company said in a Nov. 18 news release.
  • Tissue sectioning robot company lands $32M funding

    Hawthorne, N.Y.-based medical robotics company Clarapath netted $16 million in follow-on financing after a previous close of $16 million in series B funding, the company said in a Nov. 18 news release.
  • Lab tech job market: growth projections, pay and other essential data

    The COVID-19 pandemic brought higher visibility to medical labs and the people who make them run. Becker's Hospital Review has compiled job data for lab technicians and distilled it to the most essential data points.
  • Smallpox-labeled vials unearthed in Pennsylvania Merck lab

    A Merck lab worker in Pennsylvania found five vials labeled "smallpox" in a lab freezer, according to a Nov. 18 New York Times report. The worker was masked and gloved.
  • $5M lab supply deal inked for Medline, Texas system

    Northfield, Ill.-based Medline, the largest private medical supply manufacturer and distributor in the U.S., landed a $5 million deal with Edinburg, Texas-based DHR Health, the company said in a Nov. 16 news release.
  • HHS reinstates FDA review of lab-developed COVID-19 tests

    HHS is withdrawing a 2020 policy that limited the FDA's review process of certain lab tests, including some COVID-19 tests, the agency said Nov. 15.
  • Cancer lab firm names Dave Daly to its board

    Cancer-focused genetic testing services firm NeoGenomics, based in Fort Myers, Fla., has named Singular Genomics President and COO Dave Daly to its board, according to a Nov. 14 Business Observer report.
  • Lab owner sentenced to 82 months in prison for Medicare kickback scheme

    Leonel Palatnik, 42, co-owner of Dallas-based Panda Conservation Group, a medical lab company, was sentenced to 82 months in prison for his role in a $73 million Medicare kickback scheme, according to a Nov. 9 Justice Department news release.
  • Alleged fake COVID-19 testing lab may have to refund patients

    A now-closed New Jersey lab could have to pay hundreds of patients back for allegedly selling and administering fake COVID-19 tests, according to a Nov. 9 report by NBC affiliate WNBC.
  • Audit finds Iowa lab left up to $1.1M on the table

    An internal audit found that the University of Iowa's State Hygienic Laboratory left as much as $1.1 million on the table, thanks to inconsistent billing and document collection, according to a Nov. 8 report in The Gazette.
  • Lab test owner indicted in $100M fraudulent billing scheme

    An Arkansas man who owned and managed several diagnostic testing laboratories was indicted in an alleged $100 million fraudulent billing scheme, the Justice Department said Nov. 3. 
  • Joint venture building 100,000-square-foot lab in Los Angeles

    A joint venture between Los Angeles-based real estate firm Hatchspaces and Denver-based healthcare developer NexCore Group is building a life sciences wet lab in West Los Angeles, the companies said in a Nov. 3 news release.
  • Joint Commission and American Society for Clinical Pathology launch lab designation program

    The American Society for Clinical Pathology and the Joint Commission are kicking off a lab recognition program, the organizations said in an Oct. 27 news release.
  • Notre Dame lab partners with blockchain firm to combat fake drug circulation

    Cambridge, Mass.-based blockchain platform Artifacts is partnering with South Bend, Ind.-based University of Notre Dame's Distributed Pharmaceutical Analysis Lab to combat the circulation of fake and substandard drugs, the university said in an Oct. 20 news release.
  • Nevada clinical lab to pay up to $16M over fraud allegations 

    Nevada-based clinical laboratory MD Labs and two of its owners and co-founders will cumulatively pay between $11.6 million and $16 million to resolve allegations that they billed federal programs for medically unnecessary urine drug testing, according to a Justice Department statement.
  • Labs of All Sizes Can Benefit From Employing Revenue-enhancing Best Practices

    Before the pandemic, many laboratories were already facing financial challenges due to severe downward pricing pressure caused by multi-year price cuts to the Medicare Part B clinical laboratory fee schedule.
  • Disruption forces Minnesota lab to send COVID-19 tests to New Jersey

    An Oakdale, Minn. lab owned by Piscataway, N.J.-based Infinity BiologiX experienced an unspecified disruption in services over the weekend of Oct. 16-17, according to Saint Paul, Minn., ABC affiliate KSTP.
  • Former CEO of defunct medical lab settles kickback civil case for $1.1M

    Jae Lee, former CEO of the now-defunct Northwest Physicians Laboratory in Bellevue, Wash., agreed to pay $1.1 million to resolve a civil case involving the lab allegedly offering referrals in exchange for cash payments, an arrangement commonly known as a kickback, according to a Justice Department news release.
  • Chicago lab tracks COVID-19 through wastewater

    A University of Illinois Chicago lab has been tracking COVID-19 in the city's wastewater and sharing the results with local public health agencies, according to WTTW.

Featured Whitepapers

Featured Webinars